The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?
- PMID: 30206716
- DOI: 10.1007/s12032-018-1205-5
The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?
Comment on
-
The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes.Med Oncol. 2018 Feb 8;35(3):33. doi: 10.1007/s12032-018-1094-7. Med Oncol. 2018. PMID: 29417235
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources